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doi:10.1016/j.ejvs.2008.09.009Abstract Objective: To assess the efficacy of endovenous laser therapy (EVLT) for treating
saphenous reflux associated with varicose veins.
Design: Out-patient treatment by EVLT with an 810 nm laser wavelength with results assessed
by ultrasound surveillance.
Patients: 361 patients who received EVLT for 509 incompetent saphenous veins over a five-year
period.
Methods: EVLT was used for proximal saphenous veins and ultrasound-guided sclerotherapy
(UGS) for distal saphenous veins and tributaries. Control of reflux and occlusion or obliteration
of the saphenous veins was assessed by serial ultrasound studies. Univariate KaplaneMeier life
table analysis showed cumulative primary and secondary success rates, and multivariate Cox
regression analysis assessed covariates that could be associated with increased risk of ultra-
sound failure.
Results: Life table analysis showed primary success at four years in 76% (95% CI 56e87%) and
secondary success at four years after further treatment of recurrence by UGS in 97% (95% CI
93e99%). Cox regression analysis showed a non-significant trend towards worse primary
success in male patients and worse results for older patients and limbs with clinical CEAP cate-
gories C4e6. Cox regression showed significantly worse secondary success for limbs with
clinical CEAP C4e6.
Conclusions: EVLT effectively controls saphenous reflux particularly with ultrasound surveil-
lance to detect early recurrence that can be treated by UGS. Modifications in technique
may be required to improve the late primary success rate.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.294166; fax:þ61 394271926.
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Treatment of saphenous vein reflux by surgery leads to
disruption of activities, appreciable trauma, scarring and
high late recurrence rates.1 Non-surgical endovenous
techniques are becoming increasingly popular with practi-
tioners and patients. Endovenous laser therapy (EVLT)
provides a percutaneous method to destroy larger diameter
saphenous veins. EVLT is an out-patient procedure per-
formed under local anaesthesia and is associated with
minimal post-treatment morbidity and no surgical trau-
ma.2e5 This article analyses medium-term results after
EVLT for 509 saphenous veins in 361 patients followed by
ultrasound surveillance.
Patients and Methods
The procedure was introduced in January 2002 with follow-
up for analysis continued until June 2007. All patients were
treated by the one surgeon (KM). Ethics committee
approval had been obtained for endovenous treatment of
varicose veins. EVLT was offered to patients where
preliminary ultrasound scanning showed great or small
saphenous reflux with a straight section of vein of diameter
greater than approximately 5 mm. Duplex scanning per-
formed by specialist vascular sonographers linked to the
surgical unit was used to detect superficial, deep and
perforator reflux, mark the site and extent of disease, and
measure the length and diameters of refluxing saphenous
veins prior to the procedure.
Technique for EVLT
EVLT was performed using the Diomed 810 nm diode system
(Diomed Inc., Andover, MA, USA) under tumescent anaes-
thesia without sedation. Ultrasound imaging was used with
a 12e5 MHz linear array probe. The distal end of vein and
saphenofemoral or sapheno-popliteal junction were
marked. The limb was draped and the operator wore
a surgical gown and gloves. The skin at the puncture site
was infiltrated with 1% plain lidocaine and a 19 g angiogram
inserted under longitudinal ultrasound imaging. A 0.035 in.
safety-J guidewire was passed along the vein to the
saphenous junction, and a 45 cm long 5F sheath is passed
over the wire to the junction. Occasionally the vein had to
be treated in two sections if the guidewire could not be
passed the full length of the vein.
Ultrasound was used to guide injection of 10e15 ml
aliquots of 0.2% lidocaine with adrenaline solution through
a 25 gauge needle into the saphenous fascial compartment in
which the vein lies along the entire length to be treated. A
laser fibre was passed along the sheath, markers on the fibre
allowing 2 cm of it to extend beyond the sheath. The tip was
placed 2 cm below the saphenous junction confirmed by
transillumination using the laser aiming beam. The fibre tip
was placed above major thigh tributaries of the GSV. When
treating the small saphenous vein the fibre was passed into
the thigh extension of the SSV where this was possible.
The treatment power used in this series was 14 watts
continuous power. The mean rate of withdrawal of the
probe ranged from 1.3 to 8.8 mm/sec (median 3.1 mm/sec)e the faster rates were used early in the study. The mean
power used ranged from 16 to 128 joules/cm (median
44 joules/cm).
Once the saphenous trunk had been treated the
compression was applied with both bandages and a class 2
stocking. Immediate walking was encouraged. Compression
with the stocking and bandages was maintained for 48 h and
the stocking alone was then worn during the day for
a further 7e10 days. Pain was readily controlled by oral
analgesics and most patients were able to resume normal
activities by the next day.
Further treatment by UGS for residual varices and
saphenous trunk was required after 80% of procedures and
usually performed 1e3 weeks after EVLT. Incompetent
saphenous were treated in 70% of cases and the distal
saphenous vein in 10%. UGS is performed with a 1.5% solu-
tion of sodium tetradecyl sulphate foamed with air or
carbon dioxide/oxygen in a ratio of two parts fluid to three
parts gas using a sufficient volume to fill the veins (median
5 ml). No surgical treatment was required in any limb.
Ultrasound surveillance
It was considered essential to repeat ultrasound at 3e5
days after the procedure to confirm that the treated vein
had been occluded, to detect residual veins to be treated,
and to exclude deep vein occlusion. The scan is repeated at
6 weeks, 6 monthly for 2 years then annually, looking for
occlusion or obliteration, or for recanalisation of the vein.
Statistical analysis
Follow-up with serial ultrasound scans at the above inter-
vals was used for survival analysis. Success was defined as
continuing occlusion or obliteration without reflux in any
segment of the treated vein determined by duplex ultra-
sonography. Primary failure was defined as failure to
occlude the lumen or recanalisation with reflux in a part or
all of the treated saphenous vein, whether or not this was
associated with clinical persistence or recurrence of vari-
cose veins. Secondary failure was defined as failure to
occlude the lumen or recanalisation and reflux after
primary failure, either because of a decision for no further
treatment or if further treatment by UGS was unsuccessful.
Data were progressively censored as patients were seen
at the most recent visit, were lost to follow up or died.
Statistical analysis was performed using Stata V9.2 soft-
ware. Univariable KaplaneMeier survival-curve analysis was
used to calculate primary and secondary ultrasound success
rates. The time to failure was the difference between the
date of EVLT and date that recurrent reflux was demon-
strated at follow-up. All patients presented for this first
post-procedure scan and if failure was noted at this scan
then this date was used for failure although it is probable
that the procedure had failed from the time it was per-
formed. If a patient shown to have recurrence had missed
a prior scheduled visit then recurrence was dated back to
the time of that missed visit.
Multivariable Cox proportional hazard regression anal-
ysis was used to correlate success or failure independently
with various covariates relating to the patients, limbs,
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side, clinical CEAP category (C2e3 vs C4e6), vein treated
(great or small saphenous), primary disease without
previous treatment or recurrence after previous surgery,
time for the date of procedure from the date for
commencement of the surgeon’s experience (days), length
of vein treated (cm), representative diameter of vein
(mm), rate of withdrawal of the laser probe (mm/sec), and
power used (joule per cm).
To avoid linearity assumptions, we categorized contin-
uous covariates. We selected categories based on quartiles
of the variable’s distribution, independent of its association
with the outcome variable. We used a likelihood-ratio c2
test to assess the contribution of each predictor variable in
a final model. The unit of analysis for Cox proportional
hazard regression was the vein. We used the Huber/White
sandwich estimator of variance to accommodate clustering
of veins within the same patient. Each vein inherited the
higher-level characteristics of its ‘parent’ limb and patient
within the regression model.
Results
Patients and veins treated
EVLT was offered to patients where preliminary ultra-
sound scanning showed great or small saphenous reflux
with a straight section of vein of diameter greater than
approximately 5 mm. 509 saphenous veins were treated
in 494 limbs of 361 patients. No patient has been
excluded from the follow-up. There were 232 women
(64%) and 129 men with an age range from 24 to 76 years
(median 52 years). Both the great and small saphenous
veins of the same limb were treated at the one procedure
in 14 limbs of 12 patients. The great, small and anterior
accessory saphenous veins of the same limb were treated
at the one procedure in one patient. A saphenous vein
from each limb was treated in 133 patients, initially as
separate procedures but then always at the one session.
The CEAP classification showed that there were 449 limbs
with uncomplicated varicose veins (C2e3e91%) and 45 limbs
with complications (C4e6) due to lipodermatosclerosis
(n 34), healed past venous ulceration (n 5) or activeFigure 1 Histogram for distribution of diamulceration (n 6). Primary disease (Pp) was present in all
limbs and none had features of the post-thrombotic
syndrome. Therewas persistent or recurrent refluxafter past
saphenous surgery by other surgeons in 48 limbs, 39 for great
saphenous and 9 for small saphenous disease.
Results will be analysed for the great and anterior
accessory veins grouped together and for the small saphe-
nous veins and thigh extensions together. Treatment was
for reflux in 405 great saphenous veins, 8 anterior accessory
saphenous veins, and 96 small saphenous veins including
the thigh extensions if diseased. The diameters ranged from
4 to 17 mm (median 7 mm) for great and anterior accessory
saphenous and 4 to 10 mm (median 7 mm) for small
saphenous veins (Fig. 1). The lengths of veins treated
ranged from 10 to 48 cm (median 30 cm) for great and
anterior accessory saphenous and 6 to 38 cm (median
18 cm) for small saphenous veins (Fig. 2).
Initial technical failure occurred in 5 of 509 procedures.
In one limb treated for small saphenous reflux, the guide-
wire and laser probe passed outside the vein without this
being recognized until after the procedure. In four other
limbs treated for great saphenous reflux, it was considered
that a large vein had not been adequately compressed onto
the laser probe to achieve occlusion. There were 24 further
limbs where recanalisation was detected on surveillance,
usually to a minor degree when compared to the initial
reflux. Recurrence followed EVLT for the great saphenous
vein in 19 limbs, all from the saphenofemoral junction into
the saphenous vein in 14 and a large thigh tributary in 5.
Recurrence after EVLT for the small saphenous vein
occurred in 5 limbs, all from the sapheno-popliteal junction
into the small saphenous vein. Most recurrences occurred
within the first 18 months but three late great saphenous
recurrences were detected more than three years after
treatment (Fig. 3).
This resulted in a primary ultrasound success rate at four
years by life table analysis of 75.7% (95% CI 56.3e87.4%)
(Fig. 4). All but 5 of these limbs were treated by UGS to
obliterate the recurrent vein at intervals from 7 to 570 days
after EVLT, and this has been successful to date in all limbs
resulting in a secondary ultrasound success rate at four years
by life table analysis of 97.2% (95% CI 93.2e98.9%) (Fig. 5).
Cox regression analysis for primary success showed that
the only significant covariate relating to failure was gendereters of great and small saphenous veins.
Figure 2 Histogram for distribution of lengths of great and small saphenous veins.
242 K.A. Myers, D. Jolleywith better results in women (hazard ratio (HR) 0.44; 95% CI
0.20e1.00) (Fig. 6). There was a trend to worsen results in
older patients aged greater than 60 (HR 1.51; 95% CI 0.53e
4.31) and limbs with CEAP clinical C4e6 (HR 2.25; 95% CI
0.91e5.59) (Fig. 7) but these do not reach significance. Cox
regression analysis for secondary success showed that the
only significant covariate relating to failure was clinical
CEAP C 4e6 (HR 12.24; 95% CI 2.02e74.07) (Fig. 8). Results
are shown in Table 1. There was no significant influence on
primary success according to the side, vein treated,
primary disease without previous treatment or recurrence
after surgery, the surgeon’s experience, length of vein,
representative diameter, rate of probe withdrawal or laser
power.
Complications
One patient with very severe right heart failure and high
venous pressures causing intermittent bleeding from vari-
ces developed severe painful inflammatory swelling along
the treated great saphenous vein, and this was the only
patient who subsequently died at 18 months from cardiac
disease, unrelated to EVLT. Otherwise, all patients had
temporary mild-to-moderate pain that was controlled by
oral analgesics with no more than moderate bruising along
the site.Figure 3 Histogram for times of primThromboembolic events occurred in 11 patients (3.0%).
After EVLT for the great saphenous vein, there were two
procedures where thrombus extended into the common
femoral vein and two with thrombus in the popliteal vein at
the first scan after EVLT. One patient developed symp-
tomatic pulmonary embolism confirmed by CT scanning at
three days with no deep vein thrombosis identified and no
long-term sequelae. In addition, there were four limbs with
tibial vein occlusions all occurring after UGS performed 1e4
weeks after EVLT. After EVLT for the small saphenous vein,
one procedure was complicated by thrombus extension into
the popliteal vein and one with non-occlusive thrombus in
the femoral vein at the first scan, but there were no tibial
vein occlusions. All deep vein occlusions were asymptom-
atic and detected only by ultrasound. Above-knee throm-
boses did not occlude the vein and completely resolved
within one to two weeks. Tibial vein occlusions did not
extend but also did not recanalise.
One patient has a partial sural nerve palsy at 18 months
after small saphenous EVLT but there were no other nerve
injuries or thermal damage. No other significant complica-
tions were encountered.
Discussion
EVLT is equally suited to young patients requiring the best
cosmetic outcome and elderly patients with complicationsary success and failure for all veins.
Figure 4 KaplaneMeier life table analysis of primary success
rates after endovenous laser therapy for all veins treated.
Figure 6 KaplaneMeier life table analysis of primary success
rates after endovenous laser therapy according to sex of the
patients.
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thesia allows veins of any diameter or length to be treated
by EVLT but it is probably necessary to ensure that large
diameter veins are adequately compressed. There is little
information about the best protocol for rate of withdrawal
of the probe and power applied for any of the laser
frequencies used and it is possible that the thermal damage
was too low in this study and that late results might have
been improved by using more power.
It was not possible from the post-operative scans in this
study to determine the mechanism whereby the vein was
occluded. The usual early appearance of a non-echoic
lumen suggesting thrombosis quickly converted to an echoic
lumen suggesting fibrosis with shrinkage leading to a fine
white cord. However, this was not evaluated systemati-
cally. It has been considered by some that EVLT with the
810 nm probe acts through haemoglobin to damage the vein
by forming steam leading to endothelial denudation,
collagen contraction and vein wall fibrosis6e8 although the
mechanism for any wavelength is uncertain.9
We have previously reported our early experience with
EVLT.10 In the present expanded series, life table analysis
showed ultrasound control in 76% at four years. Most were
relatively easy successfully to treat with further UGSFigure 5 KaplaneMeier life table analysis of secondary
success rates after endovenous laser therapy for all veins
treated.resulting in secondary success at four years in 97%, with
only 5 patients electing not to have further treatment. Min
and colleagues showed similar results.2 Early studies
reported satisfactory results for the great2e4 and small5
saphenous veins although life table analysis was not used
to present results. More recent studies show excellent
results for the great and small saphenous veins.10e12 At
least two non-randomized13,14 and two randomized15,16
trials comparing EVLT and surgery for great saphenous
reflux show early outcome to be at least as good for EVLT
as for surgery, including technical success, safety, post-
operative pain, quality of life and cost-effectiveness. Early
results at 6 months from a randomized Danish study show
comparable early success, patient recovery times and time
to return to work, and post-operative pain and need for
analgesics.16
Ultrasound surveillance detects a high incidence of
failure after surgery for varicose veins.1 Van Rij and
colleagues detected 25% recurrence after great saphenous
surgery and 50% recurrence after small saphenous surgery at
three years.17 A Swedish study 10 years after great saphe-
nous ligation and stripping showed that 86 of 100 limbs hadFigure 7 KaplaneMeier life table analysis of primary success
rates after endovenous laser therapy according to clinical CEAP
of the limbs.
Figure 8 KaplaneMeier life table analysis of secondary
success rates after endovenous laser therapy according to
clinical CEAP of the limbs.
244 K.A. Myers, D. Jolleyrecurrence involving segments of the great saphenous
veins.18 There is a high incidence of reconnection from the
common femoral vein or low abdominal or pelvic veins to
thigh tributaries after surgery.19,20 Traditional teaching to
ligate all tributaries at the saphenofemoral junction may
actually predispose to reconnections into thigh veins rather
than normal drainage through the saphenous junction.
Endovenous techniques are not associated with a high inci-
dence of recurrence in the groin 21,22 suggesting that leaving
low abdominal or pelvic tributaries may be an advantage.
Ultrasound after small saphenous surgery demonstrated
that only 39% of 59 operations were successful at early
follow-up in a British report,23 and only 5 of 28 operations
were successful at 3 months in a Dutch study.24 A British
review suggests that this may be due to reluctance to strip
the small saphenous vein because of fear of nerve injury.25
An alternative endovenous technique using thermal
ablation from a radiofrequency probe (RF) shows goodTable 1 Cox regression analysis for covariates that influ-








Female 0.44 0.19e0.99 0.047
CEAP C2e3a 1.00
C4e6 2.25 0.91e5.59 0.080
Age 0e39a 1.00
40e49 0.43 0.11e1.66 0.218
50e59 0.46 0.15e1.36 0.160
60þ 1.51 0.53e4.31 0.439
Secondary success
CEAP C2e3a 1.00
C4e6 12.24 2.02e74.1 0.006
a Baseline category.results with low complication rates.26 Ultrasound surveil-
lance shows occlusion of most saphenous veins and infre-
quent development of new veins in the groin with this
technique.27 Randomized trials of RF vs surgery found
significantly less post-operative pain, faster rehabilitation,
lower cost and persisting better quality of life, as well as
comparable control of the veins.28,29 Reports show satis-
factory outcome after treatment for saphenous reflux by
UGS30e32 but we have demonstrated worse results for larger
diameter saphenous veins.33
Thromboembolic complications occur with any treat-
ment for varicose veins and EVLT had a 3% incidence of
thromboembolic complications in this series. Van Rij and
colleagues documented deep vein thrombosis in 5.3% of
limbs after varicose vein surgery although most were
localized to tibial veins.34
Varicose veins are an extremely common problem in the
community. Their treatment places a considerable strain on
the medical system with long waiting times for operation in
public hospitals. Endovenous procedures allow for more
efficient management of large numbers with out-patient
treatment. EVLT is simple to perform, well accepted by
patients, and relatively atraumatic and safe. This study
shows that EVLT is effective for dealing with varicose veins
with saphenous reflux. It may well be that success rates will
improve with increasing power applied to the veins as
suggested by Proebstle.35 Longer follow up is required to
allow confidence of lasting success. Ongoing randomized
trials will be required to better assess the value of EVLT
compared to surgery.
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